Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi

Pierre I. Karakiewicz, Nazareno Suardi, Claudio Jeldres, Pascale Audet, Pierre Ghosn, Jean Jacques Patard, Paul Perrotte

Research output: Contribution to journalArticlepeer-review

Abstract

A 75-yr-old previously healthy woman presented with gross hematuria, European Cooperative Oncology Group 0, and an 11-cm renal mass with right atrial thrombus. The patient refused the sternotomy. She was offered two cycles of sunitinib maleate (Sutent) induction therapy to down-stage the thrombus and to reduce the extent of the surgery.

Original languageEnglish
Pages (from-to)845-848
Number of pages4
JournalEuropean Urology
Volume53
Issue number4
DOIs
Publication statusPublished - Apr 2008

Keywords

  • Renal cancer
  • Sunitinib
  • Thrombus

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi'. Together they form a unique fingerprint.

Cite this